The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Plerixafor
Plerixafor · PLERIXAFOR 24 mg/1.2mL · Injection, Solution · Subcutaneous · Camber Pharmaceuticals, Inc.
NDC 31722-0373-31 · 1 VIAL, SINGLE-USE in 1 CARTON / 1.2 mL in 1 VIAL, SINGLE-USE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Hetero Labs LimitedIndiamanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $3,270.74 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA217560
- TE code
- AP
- Approval date
- Jun 16, 2025
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)Mar 13, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Plerixafor (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi Usa, LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | PLERIXAFOR 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sanofi-Aventis U.S. LLC | PLERIXAFOR 24 mg/1.2mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Plerixafor — NDC 31722-0373-31," retrieved September 3, 2026, https://drugdashboards.com/drug/31722037331.
Free to cite with attribution — see how the data is put together.